Tata Group set to acquire major stake in e-pharmacy firm 1mg

In August, Reliance Retail, a subsidiary of India’s largest business conglomerate Reliance Industries, acquired a 60% stake in Vitalic, the parent company of Chennai-based online pharmacy startup Netmeds, in a deal valued of about Rs 620 crore.

Advertisement

Tata Group is planning to step in the online pharmacy sector with ongoing talks to purchase a large stake in the Gurgaon-based 1mg, in light of the rapid growth of the e-pharmacy sector resulting from the Covid-19 outbreak.

In August, Reliance Retail, a subsidiary of India’s largest business conglomerate Reliance Industries, acquired a 60% stake in Vitalic, the parent company of Chennai-based online pharmacy startup Netmeds, in a deal valued of about Rs 620 crore.

If the deal with the American based Sequoia-Capital backed company 1mg is finalized, it could significantly change the face of the thriving e-pharmacy industry in India, with 2 of the countries biggest business conglomerates armed to face-off for the biggest chunk of action in the pharma market.

Reliance entry in the e-pharmacy sector is aligned with Amazon’s decision to model a Bengaluru based prescription drug delivery service in partnership with Cloudtail. Amazon has a 24 percent stake in the parent company Cloudtail. The strategic investments in India’s online pharmacy sector have set off a wave of consolidation, with Mumbai-based Pharmeasy — backed by Temasek, CDPQ and Orios Venture Partners — entering into a deal to merge with its smaller Bengaluru-based rival Medlife.

The Gurugram-based 1mg, Pharmeasy, Netmeds and Medlife are the four largest online pharmacies in the country and have offered a range of services to secure a stronger consumer base with online lab testing, doctor consultations, and even insurance claims management services. They also developed a portfolio of private label products in the nutrition and supplements category. The e-pharmacy industry witnessed a blow post the imposition of COVID-19 lockdown, which was followed by a boom post the government’s recognition of the importance of the sector, with sales almost doubling in the initial months.

Post the initial slump in the, according to Frost & Sullivan, e-pharmacies made inroads into about 9 million households in the country due to the lockdown, and the sector was expected to reach 70 million households by 2025, expanding to over 75 companies.

Subscribe to our newsletter
Subscribe to our newsletter
Sign up here to get the latest news delivered directly to your inbox.
You can unsubscribe at any time